Sunshine Biopharma

Sunshine Biopharma EBIT Margin

The EBIT Margin (Operating Margin) of Sunshine Biopharma (SBFM) as of Oct 31, 2026 is -12.34 %. In the previous year, EBIT Margin (Operating Margin) was -16.67 % — a change of -25.98% (higher).

EBIT Margin

-12.34 %

YoY

-25.98%

Last updated:

EBIT Margin (Operating Margin) of Sunshine Biopharma is 2025 -12.34 % . EBIT Margin (Operating Margin) of Sunshine Biopharma was 2024 -16.67 % . It decreases by -25.98% higher compared to the previous year.

Sunshine Biopharma's operating (EBIT) margin stands at -12.3%, up from -1,068.2% several years earlier.

The Sunshine Biopharma EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
-446.50 USD
Jan 1, 2019
-3,037.91 USD
Jan 1, 2020
-807.83 USD
Jan 1, 2021
-1,068.24 USD
Jan 1, 2022
-199.60 USD
Jan 1, 2023
-19.86 USD
Jan 1, 2024
-16.67 USD
Jan 1, 2025
-12.34 USD
The Sunshine Biopharma EBIT Margin history
YEAREBIT MarginYoY
-12.34 %-25.98%
-16.67 %-16.09%
-19.86 %-90.05%
-199.60 %-81.31%
-1,068.24 %+32.23%
-807.83 %-73.41%
-3,037.91 %+580.39%
-446.50 %-99.02%
-45,683.67 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Sunshine Biopharma Stock analysis

What does Sunshine Biopharma do? Sunshine Biopharma Inc., based in Pointe-Claire, Quebec, is a biotechnology company focused on developing and commercializing oncology and antiviral drugs. The company employs 46 full-time staff and operates through two segments: generic prescription pharmaceuticals and over-the-counter products. It develops proprietary drugs such as Adva-27a for pancreatic cancer, K1.1 mRNA for liver cancer, and SBFM-PL4 for antiviral applications. The firm also manages subsidiaries NoraPharma Inc. and Sunshine Biopharma Canada Inc., which handle generic and OTC product portfolios respectively. Sunshine Biopharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sunshine Biopharma stock

EBIT Margin (Operating Margin) of Sunshine Biopharma is -12.34 % in 2025.

EBIT Margin (Operating Margin) of Sunshine Biopharma changed from -16.67 % to -12.34 %, representing a -25.98% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Sunshine Biopharma since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Sunshine Biopharma with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Sunshine Biopharma

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Sunshine Biopharma